As Park Electrochemical (PKE) Market Valuation Rose, Raging Capital Management Boosted Its Holding; Chemocentryx (CCXI) Holder Carmignac Gestion Cut Its Stake

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Carmignac Gestion decreased its stake in Chemocentryx Inc (CCXI) by 5.92% based on its latest 2018Q4 regulatory filing with the SEC. Carmignac Gestion sold 76,981 shares as the company’s stock rose 6.99% with the market. The institutional investor held 1.22 million shares of the health care company at the end of 2018Q4, valued at $13.36M, down from 1.30M at the end of the previous reported quarter. Carmignac Gestion who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $781.41 million market cap company. The stock increased 2.30% or $0.33 during the last trading session, reaching $14.86. About 137,714 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 5, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 09/03/2018 ChemoCentryx 4Q EPS 80c; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

Raging Capital Management Llc increased its stake in Park Electrochemical Corp (PKE) by 93.24% based on its latest 2018Q4 regulatory filing with the SEC. Raging Capital Management Llc bought 839,715 shares as the company’s stock rose 20.59% with the market. The hedge fund held 1.74 million shares of the electrical products company at the end of 2018Q4, valued at $31.45 million, up from 900,588 at the end of the previous reported quarter. Raging Capital Management Llc who had been investing in Park Electrochemical Corp for a number of months, seems to be bullish on the $323.66 million market cap company. The stock increased 0.69% or $0.11 during the last trading session, reaching $15.96. About 34,127 shares traded. Park Electrochemical Corp. (NYSE:PKE) has risen 26.94% since April 5, 2018 and is uptrending. It has outperformed by 22.57% the S&P500. Some Historical PKE News: 20/04/2018 – DJ Park Electrochemical Corp, Inst Holders, 1Q 2018 (PKE); 14/03/2018 – Park Electrochemical Corp. Declares Cash Dividend; 07/05/2018 – Park Electrochemical 4Q EPS 88c; 02/05/2018 – Park Electrochemical Corp. Announces Qualification of Electroglide® Lightning Strike Protection Prepreg by a Major Aerospace O; 03/05/2018 – Park Electrochemical Corp. Announces Date of Fiscal Year Earnings Release and Conference Call; 07/05/2018 – PARK ELECTROCHEMICAL 4Q ADJ EPS 10C; 06/03/2018 Park Electrochemical Corp. Announces Introduction of Electroglide® Lightning Strike Protection Prepreg

Raging Capital Management Llc, which manages about $631.31 million and $695.24M US Long portfolio, decreased its stake in Harmonic Inc (NASDAQ:HLIT) by 378,548 shares to 6.03M shares, valued at $28.45 million in 2018Q4, according to the filing. It also reduced its holding in Steel Partners Hldgs LP (NYSE:SPLP) by 201,300 shares in the quarter, leaving it with 692,409 shares, and cut its stake in Fiat Chrysler Automobiles N.

Investors sentiment decreased to 1.3 in 2018 Q4. Its down 0.16, from 1.46 in 2018Q3. It dropped, as 15 investors sold PKE shares while 29 reduced holdings. 21 funds opened positions while 36 raised stakes. 17.80 million shares or 6.73% more from 16.67 million shares in 2018Q3 were reported. Arizona State Retirement reported 0.01% in Park Electrochemical Corp. (NYSE:PKE). Price T Rowe Associate Inc Md holds 13,460 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Park Electrochemical Corp. (NYSE:PKE). Jpmorgan Chase invested in 0% or 66,567 shares. Teachers Retirement Of The State Of Kentucky has invested 0% in Park Electrochemical Corp. (NYSE:PKE). Tower Lc (Trc) owns 60 shares. Marshwinds Advisory Com accumulated 28,756 shares. Gabelli Funds Llc owns 349,000 shares. The Washington-based Parametric Port Ltd Liability has invested 0% in Park Electrochemical Corp. (NYSE:PKE). Panagora Asset Mgmt Incorporated reported 135,810 shares or 0.01% of all its holdings. Guggenheim Capital Llc invested in 0.03% or 211,475 shares. Morgan Stanley stated it has 0% in Park Electrochemical Corp. (NYSE:PKE). Barclays Public Ltd holds 0% or 7,359 shares in its portfolio. State Street Corp reported 567,948 shares. State Of Alaska Department Of Revenue invested in 0% or 6,456 shares.

More notable recent Park Electrochemical Corp. (NYSE:PKE) news were published by: Globenewswire.com which released: “Park Electrochemical Corp. Declares Cash Dividend NYSE:PKE – GlobeNewswire” on March 13, 2019, also Globenewswire.com with their article: “Park Electrochemical Corp. Celebrates 65 Years In Business – GlobeNewswire” published on April 01, 2019, Globenewswire.com published: “Park Electrochemical Corp. Announces Completion of Sale of Its Electronics Business to AGC Inc. – GlobeNewswire” on December 04, 2018. More interesting news about Park Electrochemical Corp. (NYSE:PKE) were released by: Globenewswire.com and their article: “Park Electrochemical Corp. Announces Major Expansion of Its Aerospace Manufacturing, Development and Design Facilities in Newton, Kansas – GlobeNewswire” published on December 17, 2018 as well as Benzinga.com‘s news article titled: “Earnings Scheduled For October 4, 2018 – Benzinga” with publication date: October 04, 2018.

Carmignac Gestion, which manages about $6.62 billion US Long portfolio, upped its stake in Servicenow Inc (NYSE:NOW) by 57,470 shares to 926,930 shares, valued at $165.04M in 2018Q4, according to the filing. It also increased its holding in Cloudera Inc by 436,089 shares in the quarter, for a total of 2.85M shares, and has risen its stake in Becton Dickinson And Co (NYSE:BDX).

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It is negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Northern Tru Corporation invested in 0% or 299,622 shares. 10,588 were accumulated by Voya Investment Management Limited Company. Franklin Res accumulated 1.38 million shares. Barclays Public Ltd has 5,866 shares for 0% of their portfolio. 114,827 are held by Bb&T Limited Liability Company. New York-based Morgan Stanley has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). 46,700 were reported by Alliancebernstein Lp. Daiwa Group Inc reported 269 shares. Pnc Ser Gru stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Meeder Asset Management holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 3,035 shares. Tiaa Cref Inv Mgmt Limited Liability Corporation owns 311,491 shares. Bancorporation Of Montreal Can reported 129,083 shares. 23,200 were accumulated by State Of Wisconsin Invest Board. Wasatch Advsrs owns 2.32 million shares or 0.34% of their US portfolio. Bank & Trust Of New York Mellon owns 139,805 shares or 0% of their US portfolio.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Benzinga.com which released: “10 Biggest Price Target Changes For Wednesday – Benzinga” on March 27, 2019, also Nasdaq.com with their article: “After-Hours Earnings Report for March 11, 2019 : ADT, COUP, SFIX, DRNA, AVD, PETQ, CCXI, LXFR, MG, OXFD, FRTA, KALA – Nasdaq” published on March 11, 2019, Benzinga.com published: “52 Biggest Movers From Yesterday – Benzinga” on March 26, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” published on March 12, 2019 as well as Benzinga.com‘s news article titled: “Cancer Biology Clinical Research Seeking Answers at Cellular Level – Benzinga” with publication date: March 26, 2019.

Since October 16, 2018, it had 0 insider purchases, and 8 selling transactions for $87.64 million activity. Schall Thomas J. sold $447,092 worth of stock. Another trade for 7.34M shares valued at $85.85 million was made by GLAXOSMITHKLINE PLC on Tuesday, October 16. KANAYA SUSAN M had sold 37,893 shares worth $457,747.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart


Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *